Business News • PR NewsWire • The Japanese Cancer Association and Debiopharm Group(TM) Present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for Their Outstanding Oncology Research

The Japanese Cancer Association and Debiopharm Group(TM) Present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for Their Outstanding Oncology Research

The Japanese Cancer Association and Debiopharm Group(TM) Present the JCA-Mauvernay Award to Dr Ogawa and Prof. Maeda for Their Outstanding Oncology Research

LAUSANNE, Switzerland, September 24, 2010 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, today presented the 'The JCA-Mauvernay Award' t

View More : http://www.prnewswire.com/news-releases/the-japanese-cancer-association-and-debiopharm-grouptm-present-the-jca-mauvernay...

Releted News by prnewswire

Netflix and NBC Universal Announce Agreement to Stream Prior Season Cable and Broadcast TV Series New to Netflix Members

Study Shows Children Under Ten More Proficient with Technology than Reading or Writing

SunBriteTV Introduces New 22-inch All-Weather Outdoor LCD TV and Color Options at CEDIA EXPO 2010

For Fans of iPod touch 4 and iPad: 4Easysoft Studio Will Be Your Great Assistant

Freddie Mac Issues Monthly Volume Summary for August 2010